News & Articles

Public-private partnership aims to standardize and clinically validate blood-based biomarkers

New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer

Selected for screening of 340,000 recruits in 2017 as part of national TB control strategy

European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients, in line with latest WHO recommendations and clinical guidelines

PAXgene Blood ccfDNA enhances handling and workflow convenience for liquid biopsy applications in prenatal testing and cancer research

Project that measured pathogens in New York City subways goes global this summer

New follow-up assay helps stratify patients with transforming HPV infections

Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS

Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples

Reference data set from Horizon affirms proven accuracy of GeneReader workflow

Collaboration with Therawis addresses unmet need to guide clinical decisions in breast cancer

RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses

Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment

First truly end-to-end solution for next-generation sequencing receives Red Dot award

QuantiFERON®-TB Gold wins tender for testing subpopulations at risk for tuberculosis

Get to your results faster with QIAGEN

Cross-European trial shows enhanced sensitivity of fourth-generation test for tuberculosis infection